CA2737669A1 - Synthese combinatoire et utilisation de banques de sequences d'acide nucleique exprimees courtes pour l'analyse d'evenements cellulaires - Google Patents
Synthese combinatoire et utilisation de banques de sequences d'acide nucleique exprimees courtes pour l'analyse d'evenements cellulaires Download PDFInfo
- Publication number
- CA2737669A1 CA2737669A1 CA2737669A CA2737669A CA2737669A1 CA 2737669 A1 CA2737669 A1 CA 2737669A1 CA 2737669 A CA2737669 A CA 2737669A CA 2737669 A CA2737669 A CA 2737669A CA 2737669 A1 CA2737669 A1 CA 2737669A1
- Authority
- CA
- Canada
- Prior art keywords
- host cell
- cell
- ext
- biological response
- stimulus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08165151 | 2008-09-25 | ||
EP08165151.5 | 2008-09-25 | ||
PCT/EP2009/062384 WO2010034773A1 (fr) | 2008-09-25 | 2009-09-24 | Synthèse combinatoire et utilisation de banques de séquences d’acide nucléique exprimées courtes pour l’analyse d’événements cellulaires |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2737669A1 true CA2737669A1 (fr) | 2010-04-01 |
Family
ID=41335233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2737669A Abandoned CA2737669A1 (fr) | 2008-09-25 | 2009-09-24 | Synthese combinatoire et utilisation de banques de sequences d'acide nucleique exprimees courtes pour l'analyse d'evenements cellulaires |
Country Status (4)
Country | Link |
---|---|
US (1) | US20110177973A1 (fr) |
EP (1) | EP2344676A1 (fr) |
CA (1) | CA2737669A1 (fr) |
WO (1) | WO2010034773A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9580689B2 (en) * | 2010-07-22 | 2017-02-28 | Regents Of The University Of Minnesota | Induced pluripotent stem cells |
EP3342868B1 (fr) | 2016-12-30 | 2019-12-25 | Systasy Bioscience GmbH | Constructions et procédés de criblage |
EP3701015B1 (fr) * | 2017-10-24 | 2022-04-06 | Ulisse Biomed S.P.A. | Système de nanocommutateur d'amplification basé sur des enzymes de clivage spécifiques à un site fractionné permettant la détection in vitro d'analytes cibles et procédé permettant la détection desdits analytes cibles |
CN113423436B (zh) * | 2018-12-10 | 2024-02-06 | 耶鲁大学 | 塑造宿主生理学的微生物群代谢物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026123B1 (en) * | 2001-08-29 | 2006-04-11 | Pioneer Hi-Bred International, Inc. | UTR tag assay for gene function discovery |
DE10211063A1 (de) * | 2002-03-13 | 2003-10-09 | Axaron Bioscience Ag | Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo |
EP1644734B1 (fr) * | 2003-07-09 | 2011-11-23 | Life Technologies Corporation | Methode de detection d'une interaction proteine-proteine |
WO2005026686A2 (fr) * | 2003-09-09 | 2005-03-24 | Compass Genetics, Llc | Plate-forme analytique multiplexee |
WO2007087310A2 (fr) * | 2006-01-23 | 2007-08-02 | Population Genetics Technologies Ltd. | Analyses d'acides nucléiques au moyen de marques de séquences |
US20090111099A1 (en) * | 2007-10-27 | 2009-04-30 | Yongsheng Ma | Promoter Detection and Analysis |
-
2009
- 2009-09-24 US US13/120,616 patent/US20110177973A1/en not_active Abandoned
- 2009-09-24 CA CA2737669A patent/CA2737669A1/fr not_active Abandoned
- 2009-09-24 WO PCT/EP2009/062384 patent/WO2010034773A1/fr active Application Filing
- 2009-09-24 EP EP09783372A patent/EP2344676A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2344676A1 (fr) | 2011-07-20 |
US20110177973A1 (en) | 2011-07-21 |
WO2010034773A1 (fr) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lin et al. | eIF3 associates with 80S ribosomes to promote translation elongation, mitochondrial homeostasis, and muscle health | |
Deplancke et al. | A gateway-compatible yeast one-hybrid system | |
Twyman | Principles of proteomics | |
US6100035A (en) | Method of identifying cis acting nucleic acid elements | |
Stasi et al. | Two-hybrid-based systems: Powerful tools for investigation of membrane traffic machineries | |
JP2019106996A (ja) | タンパク質の安定性を測定する方法およびその使用 | |
JP2022113773A (ja) | アプタマーのためのハイスループット細胞系スクリーニング | |
US20110177973A1 (en) | Combinatorial synthesis and use of libraries of short expressed nucleic acid sequences for the analysis of cellular events | |
US20070166720A1 (en) | Small interfering RNA libraries and methods of synthesis and use | |
Ferrezuelo et al. | Bck2 is a phase-independent activator of cell cycle-regulated genes in yeast | |
Busby et al. | Enzymatic RNA Biotinylation for Affinity Purification and Identification of RNA–Protein Interactions | |
US20030082608A1 (en) | Biological assays using coded RNA reporters | |
Pillutla et al. | Target validation and drug discovery using genomic and protein–protein interaction technologies | |
Zurla et al. | Can we observe changes in mRNA “state”? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes | |
Hass et al. | A CRISPR-based yeast two-hybrid system for investigating RNA-protein interactions | |
Nishikawa et al. | De Novo Single-Stranded RNA-Binding Peptides Discovered by Codon-Restricted mRNA Display | |
US20070287153A1 (en) | Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection | |
Fan et al. | Genetically Encoded RNA Sensors for Ratiometric and Multiplexed Imaging of Small Molecules in Living Cells | |
Kasper et al. | The end game of chemical genetics: target identification | |
US20080248467A1 (en) | System for pulling out regulatory elements using yeast | |
Botvinik et al. | Linking cellular signalling to gene expression using EXT-encoded reporter libraries | |
Janitz | Assigning functions to genes—the main challenge of the post-genomics era | |
Zhang et al. | A three-hybrid system to detect and analyze RNA-protein interactions in vivo | |
Keefe | DNA-encoded Chemistry and Its Use in Discovering Chemical Probes | |
Taouji et al. | Advances in binder identification and characterisation: the case of oligonucleotide aptamers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20150924 |